VAV2 and prostate carcinoma: In a recent study, Baker et al. (2025) identified the Rac guanine nucleotide exchange factor VAV2 as a marker of poor prognosis and a signaling link that contributes to the proliferation and aggressiveness of castration-resistant prostate cancer (CRPC) cells.